Home » Authors » Brady Huggett

Articles by Brady Huggett

ZymoGenetics Raises $120M In Year’s First Biotech IPO

Feb. 4, 2002

By Brady Huggett

AltaRex Reanalyzes OvaRex IIb Results, Reaches Significance

Feb. 1, 2002

By Brady Huggett

ViaCell Files For $115M IPO To Fund Clinical Trials, R&D

Feb. 1, 2002

By Brady Huggett

ViaCell Files For $115M IPO To Fund Clinical Trials, R&D

Feb. 1, 2002

By Brady Huggett

AltaRex Reanalyzes OvaRex IIb Results, Reaches Significance

Feb. 1, 2002

By Brady Huggett

Signature Continues Acquisitions, Buys PDL’s Small-Molecule Unit

Jan. 31, 2002

By Brady Huggett

Signature BioScience Inc. is moving toward drug discovery and fueling the trek with acquisitions. (BioWorld Today)

Signature Continues Acquisitions, Buys PDL’s Small-Molecule Unit

Jan. 31, 2002

By Brady Huggett

Signature BioScience Inc. is moving toward drug discovery and fueling the trek with acquisitions. (BioWorld Today)

Set To Merge: Amgen, Immunex Report Year-End Earnings

Jan. 25, 2002

By Brady Huggett

Set To Merge: Amgen, Immunex Report Year-End Earnings

Jan. 25, 2002

By Brady Huggett

Maxim Begins Ceplene Phase III With Liver Metastases Patients

Jan. 18, 2002

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...